enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)
Go back to enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)| (NASDAQ: NVNO) | Delayed: 10.49 -0.63 (5.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.12 | 52 Week High | $ | |||
| Open | $11.49 | 52 Week Low | $ | |||
| Day High | $11.65 | P/E | N/A | |||
| Day Low | $9.97 | EPS | $ | |||
| Volume | 55,591 | |||||

